MX2010013692A - Deteccion de uso de cannabis. - Google Patents

Deteccion de uso de cannabis.

Info

Publication number
MX2010013692A
MX2010013692A MX2010013692A MX2010013692A MX2010013692A MX 2010013692 A MX2010013692 A MX 2010013692A MX 2010013692 A MX2010013692 A MX 2010013692A MX 2010013692 A MX2010013692 A MX 2010013692A MX 2010013692 A MX2010013692 A MX 2010013692A
Authority
MX
Mexico
Prior art keywords
binding partner
detection
cannabis use
thc
immunoassay
Prior art date
Application number
MX2010013692A
Other languages
English (en)
Inventor
Pulli Timo
Takkinen Kristiina
Söderlund Hans
Original Assignee
Teknologian Tutkimuskeskus Vtt Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teknologian Tutkimuskeskus Vtt Oy filed Critical Teknologian Tutkimuskeskus Vtt Oy
Publication of MX2010013692A publication Critical patent/MX2010013692A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un ligando, especialmente un fragmento de cuerpo que especialmente reconoce un complejo inmune de antígeno-aticuerpo entre anti-THC y THC (terahidrocannabinol), se describe. El ligando facilita un inmunoensayo homogéneo no competitivo para detección de uso de cannabis. Un kit de prueba que comprende en ligando es también descrito. Preferiblemente el inmunoensayo es aplicado para la prueba en camino de saliva de choferes sospechosos.
MX2010013692A 2008-06-12 2009-06-05 Deteccion de uso de cannabis. MX2010013692A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20085579A FI20085579A0 (fi) 2008-06-12 2008-06-12 Kannabiskäytön toteaminen
PCT/FI2009/050481 WO2009150295A1 (en) 2008-06-12 2009-06-05 Detection of cannabis use

Publications (1)

Publication Number Publication Date
MX2010013692A true MX2010013692A (es) 2011-03-04

Family

ID=39589343

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010013692A MX2010013692A (es) 2008-06-12 2009-06-05 Deteccion de uso de cannabis.

Country Status (20)

Country Link
US (1) US8518653B2 (es)
EP (1) EP2297585B1 (es)
JP (1) JP5675597B2 (es)
CN (1) CN102057277B (es)
AU (1) AU2009256482B2 (es)
BR (1) BRPI0915086B8 (es)
CA (1) CA2724660C (es)
CY (1) CY1117631T1 (es)
DK (1) DK2297585T3 (es)
EA (1) EA019664B1 (es)
ES (1) ES2566501T3 (es)
FI (1) FI20085579A0 (es)
HR (1) HRP20160237T1 (es)
HU (1) HUE028677T2 (es)
MX (1) MX2010013692A (es)
NZ (1) NZ589300A (es)
PL (1) PL2297585T3 (es)
SI (1) SI2297585T1 (es)
WO (1) WO2009150295A1 (es)
ZA (1) ZA201008491B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014511174A (ja) * 2011-02-07 2014-05-15 ネオトープ バイオサイエンシーズ リミテッド Ａｐｏｅ免疫療法
EP2759551B1 (en) * 2011-09-21 2019-05-22 Fujirebio Inc. Antibodies binding to an affinity complex comprising 25oh vitamin d2 or d3 and an antibody thereto
US9970950B1 (en) 2014-03-09 2018-05-15 Hound Labs, Inc. Method and apparatus for detecting acute use of target substance(s)
CN106232130A (zh) 2014-03-21 2016-12-14 St&T国际股份有限公司 大麻提取方法和组合物
IL248006B2 (en) 2014-03-27 2024-05-01 Bird Rock Bio Inc Antibodies that bind to human cannabinoid receptor 1
US10319475B1 (en) 2014-06-13 2019-06-11 Enigami Systems, Inc. Method and apparatus for determining relationships between medications and symptoms
US9726684B1 (en) 2015-01-18 2017-08-08 Hound Labs, Inc. Compositions for target substance detection and measurement
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
CN114805574A (zh) 2015-09-30 2022-07-29 鸟石生物公司 结合人大麻素1(cb1)受体的抗体
US9823259B1 (en) 2016-04-08 2017-11-21 Walter Nichols Detection device for cannabinoid use
US9933445B1 (en) 2016-05-16 2018-04-03 Hound Labs, Inc. System and method for target substance identification
US9921234B1 (en) 2016-06-17 2018-03-20 Hound Labs, Inc. Compositions and methods for detection of target constituent in exhaled breath
US11026596B1 (en) 2017-05-19 2021-06-08 Hound Labs, Inc. Detection and measurement of target substance in exhaled breath
US11187711B1 (en) 2017-09-11 2021-11-30 Hound Labs, Inc. Analyte detection from breath samples
US11860174B2 (en) 2017-12-15 2024-01-02 Bomi LLC Anti-cannabidiol antibody and uses thereof
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
US11426097B1 (en) * 2018-10-17 2022-08-30 Hound Labs, Inc. Rotary valve assemblies and methods of use for breath sample cartridge systems
US20200245898A1 (en) 2019-01-31 2020-08-06 Hound Labs, Inc. Single-use Microfluidic Cartridge for Detection of Target Chemical Presence in Human Breath
US11977086B2 (en) 2019-03-21 2024-05-07 Hound Labs, Inc. Biomarker detection from breath samples
US11933731B1 (en) 2020-05-13 2024-03-19 Hound Labs, Inc. Systems and methods using Surface-Enhanced Raman Spectroscopy for detecting tetrahydrocannabinol
US11806711B1 (en) 2021-01-12 2023-11-07 Hound Labs, Inc. Systems, devices, and methods for fluidic processing of biological or chemical samples using flexible fluidic circuits

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
DE3433652A1 (de) * 1984-09-13 1986-03-20 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren fuer haptene und proteine
WO1987007147A1 (en) * 1986-05-28 1987-12-03 Murex Corporation Method for producing monoclonal antibodies to an immunogenic antibody-antigen conjunction
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
WO1992005282A1 (en) * 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
FI20022048A0 (fi) * 2002-11-18 2002-11-18 Valtion Teknillinen Ei-kompetetiivinen immunomääritys pienille analyyteille
KR20190082996A (ko) * 2006-06-06 2019-07-10 얀센 백신스 앤드 프리벤션 비.브이. 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도

Also Published As

Publication number Publication date
EP2297585A1 (en) 2011-03-23
BRPI0915086B8 (pt) 2021-07-27
JP5675597B2 (ja) 2015-02-25
JP2011524013A (ja) 2011-08-25
NZ589300A (en) 2011-11-25
CY1117631T1 (el) 2017-04-26
AU2009256482A1 (en) 2009-12-17
CA2724660C (en) 2019-07-09
AU2009256482B2 (en) 2014-11-13
EP2297585A4 (en) 2012-05-02
US20110086364A1 (en) 2011-04-14
HRP20160237T1 (hr) 2016-04-22
CN102057277A (zh) 2011-05-11
CA2724660A1 (en) 2009-12-17
SI2297585T1 (sl) 2016-06-30
BRPI0915086B1 (pt) 2020-05-12
HUE028677T2 (en) 2016-12-28
FI20085579A0 (fi) 2008-06-12
EA019664B1 (ru) 2014-05-30
EA201071435A1 (ru) 2011-08-30
US8518653B2 (en) 2013-08-27
ES2566501T3 (es) 2016-04-13
PL2297585T3 (pl) 2016-09-30
DK2297585T3 (en) 2016-03-29
BRPI0915086A2 (pt) 2016-07-26
CN102057277B (zh) 2014-12-24
EP2297585B1 (en) 2016-03-02
ZA201008491B (en) 2011-08-31
WO2009150295A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
MX2010013692A (es) Deteccion de uso de cannabis.
BRPI0906903B8 (pt) anticorpo monoclonal e método de detecção da expressão de cd70
WO2007035633A3 (en) Screening assays and methods
TW200801202A (en) Alpha-enolase specific antibody and method of use
TW200741203A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
WO2012161288A8 (en) Immunoassay methods and reagents for decreasing nonspecific binding
BRPI0509681A (pt) aparelho e método para analisar acusticamente um fluido
WO2010051544A3 (en) Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
GB2449043A (en) Water soluble conjugates for electrochemical detection
WO2010011357A3 (en) Detection of prostate cancer using psa glycosylation patterns
MY172290A (en) Immunochromatography devices, methods, and, kits
WO2010096674A3 (en) A+ biomarker assays
EP1733234A4 (en) METHODS FOR DETERMINING AN ALLERGENIC REACTION USING IMMUNOLOGICAL ASSAY TECHNIQUES USING ORDERED MICROECHANTILLON GAMES
RS54249B1 (en) PROCEDURE FOR DETECTION OF ANTI-MEDICINAL ANTIBODIES
RU2011140471A (ru) Способ диагностики эндометриоза и диагностический набор для эндометриоза
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
WO2009055382A8 (en) One-step immunoassays exhibiting increased sensitivity and specificity
TW200622247A (en) Ileitis diagnostic assay
MX2009010751A (es) Composiciones y metodos de deteccion.
WO2007014304A3 (en) Antibody profiles characteristic of tuberculosis state
WO2010056889A3 (en) Use of an antibody and a rare-earth based crystal
MX2009012048A (es) Eliminacion de interferencia en inmunoensayos ocasionada por anticuerpos de anti-carbohidrato.
NO20052553D0 (no) Cobalaminanalyse.
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease

Legal Events

Date Code Title Description
FG Grant or registration